UBS Group
NBTX icon

UBS Group’s Nanobiotix NBTX Stock Holding History

UBS Group’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$157K Buy
5,038
+2,461
+95% +$94.8K ﹤0.01% 6904
2026
Q2 		$97.2K Sell
2,577
-2,980
-54% -$111K ﹤0.01% 7206
2026
Q1 		$172K Buy
5,557
+4,027
+263% +$106K ﹤0.01% 6719
2025
Q4 		$35.4K Sell
1,530
-631
-29% -$13.8K ﹤0.01% 7420
2025
Q3 		$40.8K Sell
2,161
-2,257
-51% -$19.2K ﹤0.01% 7705
2025
Q2 		$20.9K Buy
4,418
+1,418
+47% +$5.49K ﹤0.01% 8399
2025
Q1 		$10.7K Sell
3,000
-817
-21% -$2.82K ﹤0.01% 8601
2024
Q4 		$11K Buy
3,817
+717
+23% +$2.87K ﹤0.01% 8268
2024
Q3 		$17.8K Hold
3,100
– – ﹤0.01% 7436
2024
Q2 		$15.5K Hold
3,100
– – ﹤0.01% 7468
2024
Q1 		$20.2K Hold
3,100
– – ﹤0.01% 6927
2023
Q4 		$22.6K Sell
3,100
-706
-19% -$4.47K ﹤0.01% 7035
2023
Q3 		$33.3K Sell
3,806
-196
-5% -$1.63K ﹤0.01% 6537
2023
Q2 		$20.3K Buy
4,002
+1,002
+33% +$4.55K ﹤0.01% 6861
2023
Q1 		$10.6K Sell
3,000
-798
-21% -$3.07K ﹤0.01% 7567
2022
Q4 		$13.9K Buy
3,798
+755
+25% +$2.91K ﹤0.01% 8117
2022
Q3 		$11K Buy
3,043
+2
+0.1% +$8 ﹤0.01% 8311
2022
Q2 		$11K Sell
3,041
-778
-20% -$4.18K ﹤0.01% 7826
2022
Q1 		$26K Sell
3,819
-2,194
-36% -$17.4K ﹤0.01% 7150
2021
Q4 		$48K Sell
6,013
-54,340
-90% -$532K ﹤0.01% 6938
2021
Q3 		$686K Buy
60,353
+562
+0.9% +$7.51K ﹤0.01% 4502
2021
Q2 		$824K Sell
59,791
-10,391
-15% -$163K ﹤0.01% 4345
2021
Q1 		$1.06M Buy
70,182
+69,836
+20,184% +$1.2M ﹤0.01% 4192
2020
Q4 		$6K Buy
+346
New +$5.96K ﹤0.01% 7765

Other funds holding NBTX

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group's NBTX Position: Q3 2026 in Review

UBS Group increased its Nanobiotix (NBTX) stake by 95% in Q3 2026, buying an estimated $94.8K and bringing the position to 5,038 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #6904.

UBS Group first reported a position in NBTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.06M in Q1 2021. 10 funds tracked by Wall St. Rank hold NBTX as of Q3 2026.

  • UBS Group held 5,038 shares of Nanobiotix worth $157K as of Q3 2026.
  • UBS Group bought 2,461 Nanobiotix shares in Q3 2026, an estimated $94.8K.
  • Nanobiotix made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6904 holding.
  • UBS Group first reported a position in Nanobiotix in Q4 2020 and has held it in 24 quarters since.
  • UBS Group's Nanobiotix position peaked at $1.06M in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.